Archive: 2025/12 - Page 2
Patient Education on Generics: How to Start the Conversation with Your Doctor
Learn how to talk to your doctor about generic medications, why they're just as safe and effective as brand-name drugs, and how switching can save you money without risking your health.
How to Use Patient Counseling to Catch Dispensing Mistakes in Pharmacy Practice
Patient counseling catches 83% of dispensing errors before they reach patients-more than any other method. Learn the four-step protocol, why teach-back works, and how to make it sustainable in busy pharmacies.
Antidepressant Discontinuation Syndrome: What It Is and How to Manage It Safely
Antidepressant discontinuation syndrome causes real physical symptoms like brain zaps, dizziness, and nausea when stopping medication too quickly. Learn how to taper safely, recognize withdrawal vs. relapse, and manage protracted symptoms.
Green Coffee Extract and Stimulant Medications: What You Need to Know About Blood Pressure Risks
Combining green coffee extract with stimulant medications like Adderall or Ritalin can cause unpredictable blood pressure swings. Learn why this interaction is risky and what experts recommend.
Hydrophilic vs Lipophilic Statins: What You Need to Know About Side Effects
Understanding the difference between hydrophilic and lipophilic statins helps explain why some people experience muscle pain or other side effects. Not all statins work the same way, and your best choice depends on your health, age, and other meds.
The Science of Medication Safety: Understanding Risk, Benefit, and Real-World Evidence
Understanding medication safety means knowing how drugs are tested, how risks are found after approval, and what real-world evidence tells us about true benefits and dangers. This is the science behind every prescription.
State Laws on NTI Drug Substitution: How Rules Differ Across the U.S.
State laws on NTI drug substitution vary widely across the U.S., with 27 states restricting generic swaps for medications like warfarin and levothyroxine due to safety risks. The FDA disagrees, but patient outcomes suggest restrictions matter.
About
Medications